Analytic Investors’s PRA Health Sciences, Inc. PRAH Stock Holding History

Analytic Investors’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-42,321	Closed	-$1.92M	–	702
2015 Q4	$1.92M	Sell	42,321 -16,333	-28%	-$686K	0.02%	300
2015 Q3	$2.28M	Buy	58,654 +4,603	+9%	+$184K	0.03%	271
2015 Q2	$1.96M	Sell	54,051 -9,688	-15%	-$306K	0.03%	282
2015 Q1	$1.84M	Buy	+63,739	New	+$1.78M	0.03%	284

Other funds holding PRAH

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Analytic Investors's PRAH Position: Q1 2016 in Review

Analytic Investors sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2016, closing a stake of 42,321 shares — an estimated $1.92M sold.

Analytic Investors first reported a position in PRAH in Q1 2015 and held it in 4 quarters. The position peaked at $2.28M in Q3 2015. 154 funds tracked by Wall St. Rank hold PRAH as of Q1 2016.

Analytic Investors reported no remaining PRA Health Sciences, Inc. position as of Q1 2016 after selling out during the quarter.
Analytic Investors sold 42,321 PRA Health Sciences, Inc. shares in Q1 2016, an estimated $1.92M.
Analytic Investors first reported a position in PRA Health Sciences, Inc. in Q1 2015 and held it in 4 quarters.
Analytic Investors's PRA Health Sciences, Inc. position peaked at $2.28M in Q3 2015.
154 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2016.

Based on Analytic Investors's 13F filing for Q1 2016, filed 20 May 2016.